Assessment of myocardial salvage in patients with STEMI undergoing thrombolysis: ticagrelor versus clopidogrel

Assessment of myocardial salvage in patients with STEMI undergoing thrombolysis: ticagrelor versus clopidogrel

Abstract Background In the setting of ST-segment elevation myocardial infarction (STEMI), the faster and stronger antiplatelet action of ticagrelor compared to clopidogrel, as well as its pleiotropic effects, could result in a greater degree of cardioprotection and final infarct size (FIS) limitatio...

Full description

Bibliographic Details
Main Authors: Stylianos Petousis, Michalis Hamilos, Konstantinos Pagonidis, Panos Vardas, Georgios Lazopoulos, Ioannis Anastasiou, Evangelos Zacharis, George Kochiadakis, Emmanouil Skalidis
Format: Article
Language:English
Published: BMC 2022-07-01
Series:BMC Cardiovascular Disorders
Subjects:
STEMI
Thrombolysis
Clopidogrel
Ticagrelor
Myocardial salvage
Online Access:https://doi.org/10.1186/s12872-022-02735-1

Internet

https://doi.org/10.1186/s12872-022-02735-1

Similar Items